Tenofovir alafenamide

We are a manufacturer based in China. We specialize in providing high-quality Tenofovir alafenamide for industrial clients across various sectors. Whether you need chemicals consultation or technical support, our team is here to help.

Category:Active Pharmaceutical Ingredients   Own Brand:MT  /MOQ:100KG  /From China/  B2B only.

Tags:

Advantage:Customizable,Please tell me your specific needs↓↓↓

Introduction

Catalog ID92619 CAS NO.379270-37-8 Purity 98% MDL NumberMFCD23843796 Molecular Formula C21H29N6O5P Molecular Weight 476.466

Introduction to Tenofovir

Attribute Details
Definition Tenofovir is a nucleotide analog reverse transcriptase inhibitor (NtRTI) used primarily for the treatment of HIV-1 infection and chronic hepatitis B (HBV) infection.
Mechanism of Action Tenofovir inhibits viral replication by competing with the natural substrate deoxyadenosine 5′-triphosphate (dATP) for incorporation into viral DNA, leading to chain termination and inhibition of viral DNA synthesis.
Clinical Uses – HIV-1 Infection: Used as part of combination antiretroviral therapy (ART) to suppress viral load and boost CD4+ cell counts.<br>- Chronic Hepatitis B: Effective in reducing HBV DNA levels to undetectable levels after prolonged treatment.
Pharmacokinetics – Bioavailability: Low oral bioavailability in its parent form; administered as prodrugs (e.g., tenofovir disoproxil fumarate [TDF] or tenofovir alafenamide [TAF]) to enhance absorption.<br>- Elimination: Primarily excreted in urine via tubular secretion and glomerular filtration.<br>- Half-Life: Approximately 32 hours.
Adverse Effects – TDF: Associated with bone and renal toxicities, including decreased bone mineral density and renal impairment.<br>- TAF: Generally safer with lower nephrotoxicity and bone toxicity compared to TDF.<br>- Common Side Effects: Rash, diarrhea, headache, nausea.
Monitoring – Renal Function: Regular monitoring of renal function, especially in patients with preexisting renal impairment.<br>- Bone Density: Monitoring of bone mineral density in patients on long-term TDF therapy.
Tenofovir is a widely used antiviral agent effective against both HIV-1 and hepatitis B. Its prodrug forms, TDF and TAF, enhance its bioavailability and reduce toxicity, making it a preferred component in combination therapies. Regular monitoring of renal function and bone density is recommended, especially for patients on long-term TDF treatment.

Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.

If you're ready to take the next step, Leave your message below and we’ll reply soon. 20+ years of chemical manufacturing & export experience, a partner you can trust.

Inquiry

                               

    Factory & Shipment

    chemical factory
    chemical factory
    Powder Coatings
    chemical factory